Financials
Financial year 2026
ZimPharma from Ukkel, company number BE1008117931, closed financial year 2026 with a result of € 67,653 after tax. For that financial year ZimPharma recorded a gross margin of € 88,026 and equity of € 123,246. Compared with financial year 2025, the result moved from € 53,593 to € 67,653. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 30, 2026.
€ 123,246
▲ 122% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 67,653
▲ 26% vs 2025
Profit after tax over the fiscal year.
€ 110,392
▲ 132% vs 2025
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2026. Retained profit grew to € 121,246.
People and assets in 2026
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 982
▼ 34% vs 2025
Book value of vehicles, furniture and equipment.
Debts at end 2026
None
No bank loans on the last day of the fiscal year.
€ 42,860
▲ € 41,806 vs 2025
Supplier invoices still open on the last day of the fiscal year.
€ 26,884
▲ 16% vs 2025
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|
| Gross margin | € 68,900 | € 88,026 | ▲ 28% |
| Profit after taxes | € 53,593 | € 67,653 | ▲ 26% |
| Equity | € 55,593 | € 123,246 | ▲ 122% |
| Total debts | € 26,521 | € 69,859 | ▲ 163% |
| Cash | € 47,518 | € 110,392 | ▲ 132% |
| Land & buildings | € 1,504 | € 1,351 | ▼ 10% |
| Retained profit | € 53,593 | € 121,246 | ▲ 126% |
| Balance sheet total | € 82,114 | € 193,106 | ▲ 135% |
By gross margin, ZimPharma ranks 458th of 1323 companies with main activity “Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies” in Ukkel that publish figures (fiscal year 2026).
Key figures of ZimPharma, fiscal years 2025 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
Ask about ZimPharma the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to ZimPharma?
What happened at ZimPharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 67,653 (▲ 26% vs 2025). Source: NBB ↗
- New establishment in Ukkel. KBO
- Audrey Zimmermann became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 53,593 profit in 2025 to € 67,653 profit in 2026.
Paid € 33,093 in corporate taxes since 2025.
Best year ever: 2026, with € 67,653 profit.
Management
Behind ZimPharma is Audrey Zimmermann.
Directors
According to the 2026 annual accounts
Audrey Zimmermann
Director
since 2024
Establishments
Establishment units
Physical locations of this company
Rittwegerstraat 7A box 3
1180 Ukkel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Ukkel
Same main activity (Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies), 1535 active companies in Ukkel, largest first.
€ 15.4 million gross margin · 2025
€ 11.6 million gross margin · 2026
€ 5.2 million revenue · 2025
€ 4.2 million gross margin · 2025
€ 3.9 million gross margin · 2025
€ 3.7 million gross margin · 2025
Details
- Company number
- 1008.117.931
- VAT number
- BE 1008.117.931
- Registered office
- Rittwegerstraat 7A bus 3, 1180 Ukkel
- Names & denominations
- ZimPharma
- Enterprise type
- Rechtspersoon
- Legal form
- Besloten Vennootschap van publiek recht
- Legal situation
- Normale toestand
- Start date
- 8 April 2024
- Peppol
- Active · Active since 5 Jan 2026
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten